Differentiated Thyroid Cancer
Conditions
Interventions
Observation group:None
Sponsors
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients who have received surgical treatment and been pathologically diagnosed with differentiated thyroid carcinoma (DTC), including papillary carcinoma, follicular carcinoma and other rare subtypes of differentiated thyroid carcinoma, and undergone postoperative radioactive iodine-131 (¹³¹I) therapy; 2.Those receiving radioactive iodine-131 therapy assisted by domestic recombinant human thyroid-stimulating hormone (rhTSH) preparation; 3. Patients with basically complete clinical laboratory test results, medical history and follow-up data; 4.Aged =18 years old and having signed the broad informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients aged under 18 years; 2. Patients diagnosed with non-differentiated thyroid carcinoma; 3.Subjects with missing follow-up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse reaction;TSH level; | — |
Countries
China
Contacts
Public ContactShi He
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Outcome results
None listed